3 penny stocks to look out for in September

Do penny stocks offer exceptional growth potential? They might, if they don’t go bust first. Here are three reporting in September.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

British Pennies on a Pound Note

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Penny stocks don’t usually start out life that way. No, companies tend to pitch their shares a good bit higher when they first come to market.

And things need to go wrong to push prices down below 100p. For many years, down there is where a lot of investors have looked for recovery bargains.

I’m wondering if Allergy Therapeutics (LSE: AGY) might be one of them. A company that’s down on its luck needs to avoid going bust if it has any chance of making me a profit, of course.

And that’s probably the biggest risk with penny share diving. That appears to have been avoided though, with Allergy shares nearly trebling over the past two years.

The price is now up above 30p, but it’s been down at 7.25p. Is it good value now? A June trading update spoke of operating profit being “strong and expected to be well ahead of market expectations.” It also reports a healthy year-end cash position so, hopefully, there are no liquidity worries.

I’ll need to see the actual figures, and thankfully we should have them on 4 September when Allergy Therapeutics releases full-year results.

The allergy immunotherapy business must surely have great potential. Whether this is the company to achieve it, I don’t know. But we could have a better idea shortly.

Pandemic plus Brexit

Staffline (LSE: STAF) is a very different company, but it’s in a similar situation. The recruitment firm was hit hard by the pandemic, and was soon languishing amid the sub-20p penny stocks. Since then, we’ve seen a similar recovery to Allergy Therapeutics, and the shares are back above 80p.

First-half results are due on 14 September, and a July update suggested they should be positive. The company reckoned its trading had “continued to be strong across the first six months of the year to 30 June 2021,” ahead of expectations.

I think we’ll need to get to the end of the year before we have any meaningful profit comparatives, but I found one thing pleasing.

Staffline shouldered net debt of £36.2m at the halfway stage in 2020, but that’s been converted to £20.9m net cash this time. I think Staffline is a solid long-term business. But in the medium term, the UK is facing a post-Brexit worker shortage, which won’t help. I’ll keep watching.

Cheapest penny stock

We’re not short of options when it comes to penny stocks, and my third possibility is the most lowly priced. It’s Pan African Resources (LSE: PAF), whose shares are down at around 15p. The price has been very erratic over the years mind, dipping to 6.5p as recently as 2018.

The journey back to the current price hasn’t been all positive, with the price having reached above 27p earlier in 2021. So what we’re looking at here is a relatively small gold miner, with a market-cap of £300m.

And it’s a very erratic share price. The gold price weakness of the past few months hasn’t helped, and Pan African shares have largely followed it down.

So what now? First-half results are due on 15 September, and I’ll want to take a close look at those. In particular, I want to see how the firm’s cost of production compares to others in the same business.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »

Investing Articles

I’m expecting my Phoenix Group shares to give me a total return of 25% in 2025!

Phoenix Group shares have had a difficult few months but that doesn't worry Harvey Jones. He loves their 10%+ yield…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

14.5bn reasons why I think the Legal & General share price is at least 11% undervalued

According to our writer, the Legal & General share price doesn’t appear to reflect the underlying profitability of the business. 

Read more »